GNS has been the subject of a number of other research reports. Liberum Capital reissued a hold rating and set a GBX 2,100 ($27.61) price objective on shares of Genus plc in a research report on Monday. Numis Securities Ltd reissued a hold rating and set a GBX 1,815 ($23.86) price objective on shares of Genus plc in a research report on Thursday, September 7th. Four equities research analysts have rated the stock with a hold rating and one has issued a buy rating to the company. Genus plc currently has a consensus rating of Hold and a consensus target price of GBX 2,171.67 ($28.55).
COPYRIGHT VIOLATION NOTICE: This report was published by Community Financial News and is the sole property of of Community Financial News. If you are reading this report on another domain, it was copied illegally and republished in violation of U.S. and international copyright legislation. The legal version of this report can be read at https://www.com-unik.info/2017/10/13/genus-plc-gns-given-buy-rating-at-peel-hunt.html.
The business also recently announced a dividend, which will be paid on Friday, December 1st. Shareholders of record on Thursday, November 16th will be issued a dividend of GBX 16.20 ($0.21) per share. This is a positive change from Genus plc’s previous dividend of $7.40. This represents a yield of 0.83%. The ex-dividend date is Thursday, November 16th.
About Genus plc
Genus plc is an animal genetics company, which provides farmers with genetics that enable them to produce animal protein, in the form of meat and milk. The Company’s segments include Genus PIC, Genus ABS, Genus Asia, and Research and Development. The Genus PIC segment is engaged in porcine sales business, excluding Asia, and serves porcine customers in North America, Latin America and Europe.
What are top analysts saying about Genus plc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Genus plc and related companies.